Free Trial

Acadia Healthcare (NASDAQ:ACHC) Stock Rating Lowered by Wall Street Zen

Acadia Healthcare logo with Medical background

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Saturday.

A number of other equities analysts also recently issued reports on ACHC. Barclays dropped their price target on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Mizuho dropped their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Guggenheim started coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target on the stock. Stephens raised Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, KeyCorp dropped their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Acadia Healthcare has a consensus rating of "Hold" and an average target price of $47.94.

Read Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $22.25 on Friday. The stock's fifty day moving average is $22.68 and its 200 day moving average is $29.48. Acadia Healthcare has a fifty-two week low of $20.35 and a fifty-two week high of $82.40. The firm has a market capitalization of $2.05 billion, a PE ratio of 10.96, a PEG ratio of 4.14 and a beta of 0.93. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.35 and a current ratio of 1.35.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.84 EPS. On average, sell-side analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently bought and sold shares of ACHC. GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after acquiring an additional 3,428 shares during the last quarter. Envestnet Portfolio Solutions Inc. acquired a new stake in shares of Acadia Healthcare in the first quarter worth approximately $222,000. Sterling Capital Management LLC boosted its stake in shares of Acadia Healthcare by 59.1% in the fourth quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after acquiring an additional 2,026 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in shares of Acadia Healthcare in the first quarter worth approximately $412,000. Finally, Russell Investments Group Ltd. boosted its stake in shares of Acadia Healthcare by 21.4% in the fourth quarter. Russell Investments Group Ltd. now owns 18,421 shares of the company's stock worth $730,000 after acquiring an additional 3,248 shares during the last quarter.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

See Also

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines